Strategic Partnerships ZEPHYRx actively expands its ecosystem through partnerships with ActiGraph, Morgan Scientific, First Nation Group, Target ALS, and RxCap, signaling a growing channel strategy that sales teams can leverage to cross-sell integrated respiratory data solutions and remote monitoring capabilities.

Integrated Respiratory Stack The company offers a unified platform (spirometry, FeNO, Oscillometry, eCOA, and symptom data) that delivers cleaner data and streamlined study operations, presenting a compelling value proposition for sponsors and CROs seeking end-to-end data cohesion and faster decision making.

Decentralized Trials Growth Positioned as a provider of decentralized respiratory solutions for clinical research, ZEPHYRx aligns with market demand for remote monitoring and cloud-based spirometry, creating upsell opportunities with sponsors pursuing broader decentralized trial adoption.

Industry Alignment As an IQVIA business with a focused healthcare technology stack, ZEPHYRx sits in a favorable space for biopharma customers already working with IQVIA or similar large networks, enabling co-sales motions or refer-a-buddy opportunities to expand footprint.

Growth Signals and Scale Revenue in the low-to-mid single digits and a lean team suggest a high-velocity sales motion with potential for rapid expansion through partner-led deals and targeted outreach to mid-market and enterprise entities in medical device and respiratory care markets.